{"count": 2, "results": [{"_id": "33280183", "pmid": 33280183, "title": "The common diabetes drug metformin can diminish the action of citral against Rhabdomyosarcoma cells in vitro.", "journal": "Phytother Res", "authors": ["Duan C", "Evison A", "Taylor L", "Onur S", "Morten K", "Townley H"], "date": "2021-03-01T00:00:00Z", "doi": "10.1002/ptr.6898", "meta_date_publication": "2021 Mar", "meta_volume": "35", "meta_issue": "3", "meta_pages": "1378-1388", "score": 50262.74, "text_hl": "The common @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ drug @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can diminish the action of @CHEMICAL_citral @CHEMICAL_MESH:C007076 @@@citral@@@ against @<m>DISEASE_Rhabdomyosarcoma</m> @DISEASE_MESH:D012208 @@@Rhabdomyosarcoma@@@ cells in vitro.", "citations": {"NLM": "Duan C, Evison A, Taylor L, Onur S, Morten K, Townley H. The common diabetes drug metformin can diminish the action of citral against Rhabdomyosarcoma cells in vitro. Phytother Res. 2021 Mar;35(3):1378-1388. PMID: 33280183", "BibTeX": "@article{33280183, title={The common diabetes drug metformin can diminish the action of citral against Rhabdomyosarcoma cells in vitro.}, author={Duan C and Evison A and Taylor L and Onur S and Morten K and Townley H}, journal={Phytother Res}, volume={35}, number={3}, pages={1378-1388}}"}}, {"_id": "24391834", "pmid": 24391834, "pmcid": "PMC3877110", "title": "Metformin as an Adjuvant Drug against Pediatric Sarcomas: Hypoxia Limits Therapeutic Effects of the Drug", "journal": "PLoS One", "authors": ["Garofalo C", "Capristo M", "Manara MC", "Mancarella C", "Landuzzi L", "Belfiore A", "Lollini PL", "Picci P", "Scotlandi K"], "date": "2013-12-31T00:00:00Z", "doi": "10.1371/journal.pone.0083832", "meta_date_publication": "2013", "meta_volume": "8", "meta_issue": "12", "meta_pages": "e83832", "score": 50049.637, "text_hl": "In the present study we evaluated the in vitro and in vivo therapeutic effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ against @DISEASE_Osteosarcoma @DISEASE_MESH:D012516 @@@osteosarcoma@@@, @<m>DISEASE_Rhabdomyosarcoma</m> @DISEASE_MESH:D012208 @@@rhabdomyosarcoma@@@ and @DISEASE_Sarcoma_Ewing @DISEASE_MESH:D012512 @@@Ewing sarcoma@@@, the three most common pediatric @DISEASE_Sarcoma @DISEASE_MESH:D012509 @@@sarcomas@@@. ", "citations": {"NLM": "Garofalo C, Capristo M, Manara MC, Mancarella C, Landuzzi L, Belfiore A, Lollini PL, Picci P, Scotlandi K. Metformin as an Adjuvant Drug against Pediatric Sarcomas: Hypoxia Limits Therapeutic Effects of the Drug PLoS One. 2013;8(12):e83832. PMID: 24391834", "BibTeX": "@article{24391834, title={Metformin as an Adjuvant Drug against Pediatric Sarcomas: Hypoxia Limits Therapeutic Effects of the Drug}, author={Garofalo C and Capristo M and Manara MC and Mancarella C and Landuzzi L and Belfiore A and Lollini PL and Picci P and Scotlandi K}, journal={PLoS One}, volume={8}, number={12}, pages={e83832}}"}}]}